The elderly have the highest tuberculosis (TB) case rate compared to other age groups and are the most susceptible group for TB-associated death. However, we do not yet understand the specific mechanisms by which persistent Mycobacterium tuberculosis (M.tb) infection impacts the aging immune system or conversely, how aging contributes to the progression of latent M.tb infection to active disease. The goal of the current project is to determine the impact of aging and inflammaging on T cell control of M.tb in mice. Similar to humans, mice become more susceptible to developing primary TB or to reactivation of latent M.tb as they grow older. Thus, the aged mouse model is a good model for understanding basic principles of TB infection and immune control in the elderly. Our preliminary data show an enhanced inflammatory signature in the lung and circulation of old M.tb infected mice, and that senescence-associated immune parameters of T cells are elevated in M.tb infected mice as they age. To fully address both primary infection and reactivation of TB in the elderly, the following Aims will be performed.
Aim 1 : Determine the impact of inflammaging on susceptibility of old mice to infection with M.tb.
Aim 2 : Determine the role of senescence mediators on persistent M.tb infection. At the completion of these studies we will have provided mechanistic information on how inflammaging and immune senescence impact M.tb infection. This information is likely to be essential for understanding and managing TB disease in the elderly.

Public Health Relevance

Our understanding of how aging of the immune system impacts control of M. tuberculosis infection is limited. The studies in Project 3 will use the mouse model to elucidate the mechanism of immune control during primary TB and reactivation of latent M.tb infection in old age. Our findings are likely to extend our understanding and management of TB disease in the elderly as well as other infectious diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG051428-04
Application #
9686564
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Texas Biomedical Research Institute
Department
Type
DUNS #
007936834
City
San Antonio
State
TX
Country
United States
Zip Code
78227
Piergallini, Tucker J; Turner, Joanne (2018) Tuberculosis in the elderly: Why inflammation matters. Exp Gerontol 105:32-39
Moliva, J I; Hossfeld, A P; Canan, C H et al. (2018) Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner. Mucosal Immunol 11:968-978
Ault, Russell; Dwivedi, Varun; Koivisto, Elisha et al. (2018) Altered monocyte phenotypes but not impaired peripheral T cell immunity may explain susceptibility of the elderly to develop tuberculosis. Exp Gerontol 111:35-44
Seveau, Stephanie; Turner, Joanne; Gavrilin, Mikhail A et al. (2018) Checks and Balances between Autophagy and Inflammasomes during Infection. J Mol Biol 430:174-192
Kenney, Adam D; Dowdle, James A; Bozzacco, Leonia et al. (2017) Human Genetic Determinants of Viral Diseases. Annu Rev Genet 51:241-263
Scordo, Julia M; Arcos, Jesús; Kelley, Holden V et al. (2017) Mycobacterium tuberculosis Cell Wall Fragments Released upon Bacterial Contact with the Human Lung Mucosa Alter the Neutrophil Response to Infection. Front Immunol 8:307
Torrelles, Jordi B; Schlesinger, Larry S (2017) Integrating Lung Physiology, Immunology, and Tuberculosis. Trends Microbiol 25:688-697
Moliva, Juan I; Turner, Joanne; Torrelles, Jordi B (2017) Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol 8:407